European Medicines Agency's data protection notice on the use of SNDS data for the performance of DARWIN EU® studies on incidence and prevalence of pathologies and use of drugs in the French population
Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation: 17/12/2020, Revision: 14, Status: Authorised
Release notes - production release version 1.7.2514 - 12 March 2025 - Veterinary Medical Products Regulation: Union Product Database
Human medicines European public assessment report (EPAR): Paxneury, guanfacine, Date of authorisation: 26/02/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Status: Authorised
SPOR and XEVMPD status update webinar, Broadcast, from 8 October 2025, 10:00 (CEST) to 8 October 2025, 12:30 (CEST)
List of medicines currently in PRIME scheme
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting 24-27 February 2025
Orphan designation: Tafasitamab Treatment of follicular lymphoma, 26/02/2025 Positive
Orphan designation: Rimeporide Treatment of Duchenne muscular dystrophy, 26/02/2025 Positive